中文名 | TR-14035 |
英文名 | (S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid |
别名 | 化合物TR14035 (S)-2-(2,6-二氯苯酰胺)-3-(2,6-二甲氧基-[1,1-联苯]-4-基)丙酸 (ALPHAS)-ALPHA-[(2,6-二氯苯甲酰)氨基]-2',6'-二甲氧基联苯-4-丙酸 |
英文别名 | TR14035 MDK1191 TR 14035 TR-14035 MDK-1191 N-(2,6-Dichlorobenzoyl)-4-(2,6-diMethoxyphenyl)-L-phenylalanine (S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid (S)-2-(2,6-DichlorobenzaMido)-3-(2',6'-diMethoxy-[1,1'-biphenyl]-4-yl)propanoic acid (alphaS)-alpha-[(2,6-Dichlorobenzoyl)amino]-2',6'-dimethoxy-[1,1'-biphenyl]-4-propanoic acid |
CAS | 232271-19-1 |
化学式 | C24H21Cl2NO5 |
分子量 | 474.33 |
密度 | 1.333 |
沸点 | 604.0±55.0 °C(Predicted) |
酸度系数 | 3.53±0.10(Predicted) |
存储条件 | 2-8°C |
MDL号 | MFCD09970400 |
体外研究 | TR14035 blocks adhesion of RPMI-8866 cells to MAdCAM-Ig by 100% at 1μM, with an approximate IC 50 of 0.01μM. |
体内研究 | TR-14035 (3 mg/kg; i.g.) produces a significant decrease of the airways hyper-responsiveness to 5-hydroxytryptamine (5-HT) in an experimental model of allergic asthma in Brown Norway rats. TR-14035 exhibits plasma decreased with half-lives of 0.28 h (3 mg/kg for i.v.) and 0.39 h (10 mg/kg for i.g.), and the oral bioavailability (F) is 17%. Animal Model: Male Brown Norway rats (250-300 g) Dosage: 3 mg/kg Administration: Oral gavage, 1 h before and 3 h after antigen challenge Result: Suppressed antigen-induced airway hyper-responsiveness and inflammation. Animal Model: Male Sprague-Dawley rats (250-320 g) Dosage: 3 mg/ kg for i.v.; 10 mg/kg for i.g. Administration: Intravenous injection and oral gavage Result: T 1/2 (1.88 h for i.v.; 3.42 h for i.g.), F (17%). |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.108 ml | 10.541 ml | 21.082 ml |
5 mM | 0.422 ml | 2.108 ml | 4.216 ml |
10 mM | 0.211 ml | 1.054 ml | 2.108 ml |
5 mM | 0.042 ml | 0.211 ml | 0.422 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!